Toyama, Japan

Ayumu Mori

This inventor holds 1 USPTO granted patent. Top assignees: Taisho Pharmaceutical Co., Ltd., Toyama Chemical Co., Ltd.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ayumu Mori. Retrieved from https://idiyas.com/inventor/ayumu-mori-kp2lhkg4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ayumu Mori - Innovator in Amidine Compounds

Introduction

Ayumu Mori is a notable inventor based in Toyama, Japan. He has made significant contributions to the field of chemistry, particularly in the development of amidine compounds. His work has implications for various applications, including anti-fungal agents.

Latest Patents

Mori holds a patent for an amidine compound or salt thereof. This compound is represented by a specific formula that includes various groups and atoms, making it versatile in its applications. The compound is particularly useful as an anti-fungal agent, showcasing Mori's innovative approach to addressing health-related challenges.

Career Highlights

Throughout his career, Ayumu Mori has worked with prominent companies such as Taisho Pharmaceutical Co., Ltd. and Toyama Chemical Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in pharmaceutical chemistry.

Collaborations

Mori has collaborated with esteemed colleagues, including Tetsuya Tanikawa and Yasunobu Ushiki. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Ayumu Mori's contributions to the field of chemistry, particularly through his patent on amidine compounds, highlight his role as an influential inventor. His work continues to impact the development of effective anti-fungal agents and showcases the importance of innovation in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…